The Uncertain Role of Immunomodulator Maintenance After Cessation of Anti-Tumor Necrosis Factor α Therapy

Clin Gastroenterol Hepatol. 2015 Aug;13(8):1551-2. doi: 10.1016/j.cgh.2015.01.006. Epub 2015 Jan 16.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Crohn Disease / drug therapy*
  • Crohn Disease / pathology*
  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Infliximab / therapeutic use*
  • Male

Substances

  • Immunologic Factors
  • Infliximab